Sign in

CIK 0001674416 · Large accelerated filer

CRISPR Therapeutics AG

Sign in to watch
Ticker
CRSP
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
Switzerland
Entity type
operating
EIN
473173478
Phone
6173154600
Business address
BAARERSTRASSE 14, ZUG, Switzerland
Former names
CRISPR Therapeutics AG
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$4,881,673
in 7 filings, $1.5M under 10b5-1 plans

Net −$4,881,673. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Kulkarni Samarth −$2.6M Chief Executive Officer sold 14% of stake
  2. KASINGER JAMES R. −$797K General Counsel and Secretary sold 12% of stake
  3. Behbahani Ali −$781K Director sold 45% of stake
  4. George Simeon −$720K Director sold 48% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-03-23 Klein Lawrence Otto CBO & COO Option exercise · Stock Option (Right to Buy) −22,000 38,000
2021-03-23 Klein Lawrence Otto CBO & COO Option exercise · Stock Option (Right to Buy) −10,000 10,000
2021-03-23 Klein Lawrence Otto CBO & COO Option exercise · Stock Option (Right to Buy) −20,000 25,000
2021-03-23 Klein Lawrence Otto CBO & COO Option exercise · Stock Option (Right to Buy) −12,000 43,000
2021-03-22 Bolzon Bradley J PhD Director Sale −3,600 $129.36 $466K 57,149
2021-03-22 Bolzon Bradley J PhD Director Sale −3,413 $130.42 $445K 53,736
2021-03-22 Bolzon Bradley J PhD Director Sale −2,400 $131.14 $315K 51,336
2021-03-22 Bolzon Bradley J PhD Director Sale −6,090 $132.53 $807K 45,246
2021-03-22 Bolzon Bradley J PhD Director Sale −9,334 $133.28 $1.2M 35,912
2021-03-22 Bolzon Bradley J PhD Director Sale −5,237 $134.33 $703K 30,675
2021-03-22 Bolzon Bradley J PhD Director Sale −300 $134.93 $40K 30,375
2021-03-11 TOMSICEK MICHAEL JOHN Chief Financial Officer Option exercise · Stock Option (Right to Buy) −25,000 131,000
2021-03-11 TOMSICEK MICHAEL JOHN Chief Financial Officer Grant or award · Stock Option (Right to Buy) +25,360 25,360
2021-03-11 TOMSICEK MICHAEL JOHN Chief Financial Officer Grant or award · Restricted Stock Units +9,000 9,000
2021-03-11 Kulkarni Samarth Chief Executive Officer Grant or award · Stock Option (Right to Buy) +100,000 100,000
2021-03-11 Kulkarni Samarth Chief Executive Officer Grant or award · Restricted Stock Units +36,000 36,000
2021-03-11 Klein Lawrence Otto CBO & COO Grant or award · Stock Option (Right to Buy) +33,334 33,334
2021-03-11 Klein Lawrence Otto CBO & COO Grant or award · Restricted Stock Units +12,000 12,000
2021-03-11 KASINGER JAMES R. General Counsel and Secretary Grant or award · Stock Option (Right to Buy) +25,360 25,360
2021-03-11 KASINGER JAMES R. General Counsel and Secretary Grant or award · Restricted Stock Units +9,000 9,000

Page 30 of 46 · 910 trades